Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease
Aging Cell · 2024
DOI: 10.1111/acel.14245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2024. Verfasst von Gabrielle Zuniga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Barshop Institute for Longevity and Aging Studies, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: tau Proteins, RNA, Messenger, Protein Biosynthesis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Alterations in the rate and accuracy of messenger RNA (mRNA) translation are associated with aging and several neurodegenerative disorders, including Alzheimer's disease and related tauopathies. We previously reported that error‐containing RNA that are normally cleared via nonsense‐mediated mRNA decay (NMD), a key RNA surveillance mechanism, are translated in the adult brain of a Drosophila model of tauopathy. In the current study, we find that newly‐synthesized peptides and translation machinery accumulate within nuclear envelope invaginations that occur as a consequence of tau pathology, and that the rate of mRNA translation is globally elevated in early stages of disease in adult brains of Drosophila models of tauopathy. Polysome profiling from adult heads of tau transgenic Drosophila reveals the preferential translation of specific mRNA that have been previously linked to neurodegeneration. Unexpectedly, we find that panneuronal elevation of NMD further elevates the global translation rate in tau transgenic Drosophila , as does treatment with rapamycin. As NMD activation and rapamycin both suppress tau‐induced neurodegeneration, their shared effect on translation suggests that elevated rates of mRNA translation are an early adaptive mechanism to limit neurodegeneration. Our work provides compelling evidence that tau‐induced deficits in NMD reshape the tau translatome by increasing translation of RNA that are normally repressed in healthy cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barshop Institute for Longevity and Aging Studies, San Antonio, Texas, USA.
- Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, San Antonio, Texas, USA.
- Department of Cell Systems and Anatomy, University of Texas Health San Antonio, San Antonio, Texas, USA.
- Department of Molecular Medicine, University of Texas Health San Antonio, San Antonio, Texas, USA.
- Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe), Osaka University, Suita, Osaka, Japan.
ORCID-Profile: Bess Frost
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
- NIH HHS
- NINDS NIH HHS
- NCATS NIH HHS
- NCI NIH HHS
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Zuniga, G., Katsumura, S., De Mange, J., Ramirez, P., Atrian, F., Morita, M., & Frost, B. (2024). Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease. Aging Cell. https://doi.org/10.1111/acel.14245
Vancouver
Zuniga G, Katsumura S, De Mange J, Ramirez P, Atrian F, Morita M, et al. Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease. Aging Cell. 2024. doi:10.1111/acel.14245
BibTeX
@article{Zuniga2024,
author = {Zuniga, Gabrielle and Katsumura, Sakie and De Mange, Jasmine and Ramirez, Paulino and Atrian, Farzaneh and Morita, Masahiro and Frost, Bess},
title = {Pathogenic tau induces an adaptive elevation in mRNA translation rate at early stages of disease},
journal = {Aging Cell},
year = {2024},
doi = {10.1111/acel.14245}
}
EUVIMED